Quantum Biopharma Ltd. Files May 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 12, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-update
TL;DR
Quantum Biopharma filed its monthly 6-K, confirming it's a 20-F filer.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 12, 2025. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is a pharmaceutical preparations company. This filing is for the month of May 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's reporting status and corporate information.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the registrant
- May 12, 2025 (date) — Filing date
- Form 6-K (document) — Type of filing
- Form 20-F (document) — Annual report filing type
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of May 2025.
What is the current name of the registrant?
The current name of the registrant is Quantum BioPharma Ltd.
What was the former name of the company?
The former name of the company was FSD Pharma Inc., with a date of name change on March 27, 2019.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files annual reports under cover of Form 20-F.
Where are the principal executive offices of Quantum Biopharma Ltd. located?
The principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 regarding Quantum Biopharma Ltd. (QNTM).